Starting the Conversation about Depression and Suicide Prevention

Activity Preview

Depression is one of the most common mental health disorders in the United States. The 2016 National Survey on Drug Use and Health estimated that 16.2 million adults in the United States had at least one major depressive episode, representing 6.7% of the adult population.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

  1. Recognize the high prevalence and diverse clinical presentation of depression, and describe effective methods for pharmacists to screen for depression.
  2. Discuss the impact of stigma on depression management and ways to reduce this stigma within community pharmacy settings.
  3. Describe ways pharmacists can assess suicide risk, engage in suicide prevention, and refer patients for comprehensive evaluation and treatment.
  4. Review treatment options for depression, highlighting clinical pearls and counseling points for antidepressant therapy.

Activity type: Knowledge-based

Target Audience: Pharmacists and Pharmacy Technicians

Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-123-H04-P/T.

To obtain credit for Starting the Conversation about Depression and Suicide Prevention complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: February 1, 2019
Expiration date: February 1, 2022 - NO CREDIT GRANTED AFTER THIS DATE

Development

Starting the Conversation about Depression and Suicide Prevention is a home-study continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.

Advisory Board

Kelly N. Gable, PharmD, BCPP
Associate Professor, Department of Pharmacy Practice, Southern Illinois University Edwardsville (SIUE) School of Pharmacy, Edwardsville, IL
Julie A. Dopheide, PharmD, BCPP, FASHP
Professor of Clinical Pharmacy, Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles

Disclosures

APhA’s Government Affairs and editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website and view the Technology System Requirements to have a positive learning experience.